Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:00 PM
Ignite Modification Date:
2025-12-24 @ 11:00 PM
NCT ID:
NCT00208169
Eligibility Criteria:
Inclusion Criteria:
1. Ages 19 - 65
2. Diagnosis of schizophrenia, schizoaffective disorder, bipolar disorder, major depressive disorder, or anxiety (panic disorder, generalized anxiety disorder, or post-traumatic stress disorder) as confirmed by Mini International Neuropsychiatric Interview (MINI) structured assessment
3. Diagnosis of comorbid substance abuse/dependence as confirmed by the MINI structured assessment
4. Ability to provide signed informed consent
5. Stable general medical health
6. Ability to attend outpatient research clinic.
Exclusion Criteria:
1. Dangerous to self or others
2. Pregnancy, or inability or unwillingness to use approved methods of birth control
3. Inability or unwillingness to provide signed informed consent
4. Inability to attend outpatient research clinic
5. Medical conditions, which would preclude use of aripiprazole
6. Absolute need for ongoing treatment with antipsychotic other than aripiprazole
7. Medical instability defined as likelihood of needing to change prescription medication during the course of the study
8. Patients with prior unsuccessful treatment with aripiprazole
9. Patients with a psychiatric diagnosis of only antisocial personality disorder or only an eating disorder and comorbid substance abuse/dependence.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
19 Years
Maximum Age:
65 Years
Study:
NCT00208169
Study Brief:
Protocol Section:
NCT00208169